Joseph Arboleda
Harvard University
H-index: 25
North America-United States
Top articles of Joseph Arboleda
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A single dose for me, A wealth of protection for us: The public health cost of individualism in the rollout of COVID-19 vaccine | Social Science & Medicine | Wei Fu Li-San Wang Shin-Yi Chou | 2024/5/1 |
APOE Christchurch‐mimetic therapeutic antibody reduces APOE‐mediated toxicity and tau phosphorylation | Alzheimer's & Dementia | Claudia Marino Paula Perez‐Corredor Michael O'Hare Annie Heuer Natalia Chmielewska | 2024/2 |
Plasma Proteomics of Genetic Brain Arteriosclerosis and Dementia Syndrome Identifies Signatures of Fibrosis, Angiogenesis, and Metabolic Alterations | bioRxiv | Jonah N Keller Hannah Radabaugh Nikolaos Karvelas Stephen Fitzsimons Scott Treiman | 2024 |
Effects of APOE4 and education on the clinical onset of autosomal dominant Alzheimer’s disease due to the PSEN1 E280A mutation (S39. 004) | Nicholas Barksdale Stephanie Langella Daniel Vasquez David Aguillon Yinghua Chen | 2023/4/25 | |
Nucleic acid-based compositions and methods for treating small vessel diseases | 2023/6/22 | ||
Topotecan for proliferative vitreoretinopathy | 2023/11/9 | ||
NOTCH3 Agonist Compositions and Methods for Treating Small Vessel Diseases | 2023/4/6 | ||
Rho kinase inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition | 2023/10/5 | ||
Methods and Materials for Treatment of Fibrosis | 2023/6/22 | ||
Blood Biomarkers and Diagnostic Methods for Small Vessel Diseases | 2023/3/16 | ||
NANO-EMULSION OF CBFß-RUNX1 INHIBITOR FOR OCULAR DRUG DELIVER | 2023/9/7 | ||
A novel anti-RUNX1 therapy modulates retinal angiogenesis: Drug delivery and in vivo efficacy | Investigative Ophthalmology & Visual Science | Said Arevalo-Alquichire William Phillip Miller Andres Muriel Leo A Kim Joseph Arboleda-Velasquez | 2023/6/1 |
The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation | Nature Neuroscience | Maxine R Nelson Peng Liu Ayushi Agrawal Oscar Yip Jessica Blumenfeld | 2023/12 |
Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotection | Brain Pathology | Julián Henao‐Restrepo Carolina López‐Murillo Pablo Valderrama‐Carmona Natalia Orozco‐Santa Johana Gomez | 2023/3 |
RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition | 2023/8/29 | ||
RUNX1 mediates retinal angiofibrosis through endothelial-to-mesenchymal transition (Endo-MT) | Investigative Ophthalmology & Visual Science | William Phillip Miller Said Arevalo-Alquichire Audrey Gunawan Elizabeth Rossin Michael O'Hare | 2023/6/1 |
Differential spatial transcriptome profile of the hippocampal formation of protected PSEN1 E280A familial Alzheimer’s disease cases | Alzheimer's & Dementia | Nelson David Villalba‐Moreno Jessica Lisa Littau Yassir El Amri Francisco Lopera Andres Villegas ‐Lanau | 2023/12 |
APOE3 Christchurch modulates tau phosphorylation and β-catenin/Wnt/Cadherin signaling in induced pluripotent stem cell-derived cerebral organoids from … | bioRxiv | RC Mazzarino P Perez-Corredor TE Vanderleest GN Vacano JS Sanchez | 2023/1/13 |
Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man | Nature medicine | Francisco Lopera Claudia Marino Anita S Chandrahas Michael O’Hare Nelson David Villalba-Moreno | 2023/5 |
Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer’s disease | Nature Communications | Stephanie Langella N Gil Barksdale Daniel Vasquez David Aguillon Yinghua Chen | 2023/8/23 |
Co-Authors
